Chile vs Paraguay: The number of people with susceptibility test result for rifampicin
Chile
1,772
in 2021
Paraguay
1,639
in 2021
Chile rank
53rd
Paraguay rank
56th
The number of people with susceptibility test result for rifampicin over time
- Chile
- Paraguay
How they compare
Chile currently reports 1,772 against 1,639 in Paraguay, a difference of 133.
That makes Chile's figure about 1.1 times Paraguay's.
Across all 5 years both countries report, Chile has been ahead every year.
Chile ranks 53rd and Paraguay ranks 56th of 155 countries.
Chile has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,721 | 706 | 1,015 | Chile |
| 2020s | 1,641 | 1,204 | 437.5 | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Chile or Paraguay?
- Chile, at 1,772 against 1,639 in Paraguay as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Chile and Paraguay?
- 133, with Chile ahead.
- How many years of comparable data are there for Chile and Paraguay?
- 5 years are reported by both, from 2017 to 2021.
- How do Chile and Paraguay rank globally for the number of people with susceptibility test result for rifampicin?
- Chile ranks 53rd and Paraguay ranks 56th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.